BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Nov 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-11-12

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-12	Common Stock	S	1000	$81.5128	Disposed	228157	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	43195	Indirect

Footnotes

F1: The price in column 4 is a weighted average price. The price actually received ranged from $85.5110 to $85.52. The reporting person will provide to the issuer, and security holder of the issuers, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: The reporting person an his spouse act as trustees for the Bienaime Family Trust